GlobeNewsWire · NTLA · November 12, 2026

Intellia Therapeutics Presents Additional Positive Clinical and Patient-Reported Data for Lonvoguran Ziclumeran (lonvo-z) at ACAAI 2026

Get the app for more

Explore stock news, insights and company research.